A method of in vivo assembly of a recombinant micelle including: introducing a plasmid into a plant cell, wherein: the plasmid includes a segment of deoxyribonucleic acid (DNA) for encoding a ribonucleic acid (RNA) for a protein in a casein micelle, the segment of DNA is transcribed and translated; forming recombinant casein proteins in the plant cell, wherein: the recombinant casein proteins include a κ-casein and at least one of an αS.sub.1-casein, an αS.sub.2-casein, a β-casein; and assembling in vivo a recombinant micelle within the plant cell, wherein: an outer layer of the recombinant micelle is enriched with the κ-casein, an inner matrix of the recombinant micelle include at least one of the αS.sub.1-casein, the αS.sub.2-casein, the β-casein.

The present disclosure provides improved systems and methods for purifying and/or concentrating lentiviral compositions.

Processes and systems for filtering a liquid sample are provided. Batches of a liquid sample can be routed to two or more cycling tanks (e.g., first and second cycling tanks). Upon filling a first cycling tank, a first batch of the liquid sample can be routed to a filtration assembly by a continuous diafiltration process that includes routing produced retentate back to the first cycling tank or to a collection vessel. Upon filling a second cycling tank, a second batch of the liquid sample is routed to the filtration assembly by a continuous diafiltration process that includes routing produced retentate back to the second cycling tank or to the collection vessel. The filling and continuous diafiltration of batches of the liquid sample continues to alternate between the two or more cycling tanks until a total product volume is processed.

A disposable cell enrichment kit includes a crossflow filtration device configured to be disposed along a main loop pathway and to receive a process volume containing a biological sample and utilize crossflow filtration, via a micro-porous membrane, to retain a specific cell population in a retentate from the process volume and to remove a permeate including certain biological components from the process volume. The crossflow filtration device includes a laminated filtration unit that includes the micro-porous membrane, a first mating portion, a second mating portion, and a membrane support. The membrane support includes a first plurality of structural features that define a first plurality of openings, wherein the first plurality of structural features are coupled to the micro-porous membrane and provide support to the micro-porous membrane, and the first plurality of openings allow the permeate to flow through them after crossing the micro-porous membrane.

This disclosure relates to a method which involves the steps of: (a) providing an aqueous solution comprising a protein and a polyalkoxy fatty acyl surfactant of general formula I

##STR00001##

wherein R.sup.1—C(═O) is a fatty acyl group, R.sup.2 is H or a substituted or unsubstituted hydrocarbyl group, X.sup.1 is S, O or NH, X.sup.2 is S, O or NH, n is 0 or an integer of 1-5, R.sup.3 is a polymeric group comprising polymerized units of general formula II and III

##STR00002##

(b) contacting the aqueous solution with a separation membrane, and (c) subjecting the aqueous solution to a diafiltration step and/or to an ultrafiltration step to produce a retentate product which is an aqueous solution comprising the protein, whereby the compound of formula I reduces aggregation of the protein in method steps (a)-(c) and whereby the compound of formula I passes through the separation membrane in step (c).

A system for treating a source of water contaminated with PFAS is disclosed. The system includes a PFAS separation stage having an inlet fluidly connectable to the source of water contaminated with PFAS, a diluate outlet, and a concentrate outlet and a PFAS elimination stage positioned downstream of the PFAS separation stage and having an inlet fluidly connected to an outlet of the PFAS separation stage, the elimination of the PFAS occurring onsite with respect to the source of water contaminated with PFAS, with the system maintaining an elimination rate of PFAS greater than about 99%. A method of treating water contaminated with PFAS is also disclosed. The method includes introducing contaminated water from a source of water contaminated with a first concentration of PFAS to an inlet of a

PFAS separation stage, treating the contaminated water in the PFAS separation stage to produce a product water substantially free of PFAS and a PFAS concentrate having a second PFAS concentration greater than the first PFAS concentration, introducing the PFAS concentrate to an inlet of a PFAS elimination stage; and activating the PFAS elimination stage to eliminate the PFAS in the PFAS concentrate. A method of retrofitting a water treatment system as described herein is also disclosed. The method includes providing a PFAS elimination module as described herein and fluidly connecting the PFAS elimination module downstream of a PFAS separation stage.

Methods of producing multiple protein products from blood-based materials including alpha-1-proteinase inhibitor, gamma globulin, albumin, and other proteins are described herein. The inventive methods include steps of fractionation that utilize a combination of salt and organic solvent. Advantageously, the inventive methods are simple and produce alpha-1-proteinase inhibitor, gamma globulin, albumin, and other proteins in high yields. The sequence of process steps can be selected to obtain multiple products from various in-process materials, such as supernatants, pastes, chromatography flow-though, and chromatography washes.

Provided herein are materials and methods for the preparation of blood products. In one aspect, provided herein is a composition including platelets or platelet derivatives and an aqueous medium, wherein the aqueous medium has a protein concentration less than 50% of the protein concentration of donor apheresis plasma.

The invention relates to methods for removal of low isoelectric point product-related impurities during cation exchange purification operations.

The disclosure relates to systems and methods for improving the manufacturing of silk solutions and powders containing silk fibroin obtained from silkworm cocoons. The solutions and powders can be used to improve the post-harvest preservation of perishables and to improve the performance of packaging, including biodegradable packaging.